Henry L. Nordhoff
Chairman and Chief Executive Officer
Gen-Probe Incorporated

Henry L. Nordhoff joined Gen-Probe Incorporated in July 1994 as President and Chief Executive Officer. Following the spin-off from Chugai Pharmaceutical Co., Ltd. in September 2002, he was also appointed Chairman by the Board of Directors. Before joining Gen-Probe, Mr. Nordhoff served as President and Chief Executive Officer of TargeTech, Inc., a gene therapy company focused on the potential treatment of inherited diseases, which was merged into the Immune Response Corporation in 1992. Previously, Mr. Nordhoff spent over 16 years at Pfizer Inc. where he held several senior positions in Brussels, Seoul, Tokyo and New York.

Mr. Nordhoff serves on the Board of Directors of BIOCOM/San Diego, Molecular Light Technology in Cardiff, Wales, San Diego Economic Development Corporation, MannKind Corporation, UCSD Cancer Center, California Healthcare Institute, the Board of Trustees of the University of San Diego and the Prostate Cancer Foundation. He received his B.A. in International Relations and Political Economy from the Johns Hopkins University and his M.B.A. in International Business and Finance from Columbia University.